Free Trial

William Blair Investment Management LLC Has $177.61 Million Stake in Veeva Systems Inc. $VEEV

Veeva Systems logo with Medical background

Key Points

  • William Blair Investment Management LLC reduced its stake in Veeva Systems by 1.8%, holding 616,742 shares worth approximately $177.61 million at the end of the last reporting period.
  • Insider transactions revealed that Eleni Nitsa Zuppas sold 6,000 shares for over $1.83 million, resulting in a 19.15% decrease in ownership.
  • Veeva Systems has a consensus rating of "Moderate Buy" from analysts, with target prices ranging from $275 to $349 per share.
  • MarketBeat previews top five stocks to own in November.

William Blair Investment Management LLC lessened its stake in shares of Veeva Systems Inc. (NYSE:VEEV - Free Report) by 1.8% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 616,742 shares of the technology company's stock after selling 11,549 shares during the period. William Blair Investment Management LLC owned 0.38% of Veeva Systems worth $177,609,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of VEEV. Trust Co. of Toledo NA OH acquired a new stake in Veeva Systems in the second quarter worth $29,000. Abound Financial LLC bought a new position in shares of Veeva Systems during the 1st quarter worth about $25,000. Legacy Investment Solutions LLC bought a new position in shares of Veeva Systems during the 2nd quarter worth about $32,000. ORG Partners LLC acquired a new stake in shares of Veeva Systems in the 1st quarter valued at about $26,000. Finally, Maseco LLP bought a new stake in Veeva Systems in the 2nd quarter valued at about $35,000. 88.20% of the stock is owned by institutional investors.

Insider Buying and Selling at Veeva Systems

In other news, insider Eleni Nitsa Zuppas sold 6,000 shares of the company's stock in a transaction that occurred on Tuesday, October 7th. The stock was sold at an average price of $306.62, for a total value of $1,839,720.00. Following the completion of the transaction, the insider directly owned 25,325 shares of the company's stock, valued at $7,765,151.50. This represents a 19.15% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP Jonathan Faddis sold 720 shares of the stock in a transaction that occurred on Monday, October 6th. The shares were sold at an average price of $298.12, for a total value of $214,646.40. Following the sale, the senior vice president directly owned 7,868 shares of the company's stock, valued at $2,345,608.16. The trade was a 8.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 24,665 shares of company stock worth $7,438,000. Insiders own 10.30% of the company's stock.

Analyst Ratings Changes

Several research analysts have issued reports on the company. William Blair reiterated an "outperform" rating on shares of Veeva Systems in a report on Friday. Stifel Nicolaus upped their target price on Veeva Systems from $295.00 to $320.00 and gave the stock a "buy" rating in a research report on Thursday, August 28th. Citigroup increased their target price on Veeva Systems from $329.00 to $349.00 and gave the stock a "buy" rating in a report on Thursday, August 28th. Truist Financial lifted their price target on shares of Veeva Systems from $268.00 to $275.00 and gave the company a "hold" rating in a research report on Thursday, August 28th. Finally, KeyCorp upped their price objective on shares of Veeva Systems from $285.00 to $325.00 and gave the stock an "overweight" rating in a report on Monday, July 14th. Seventeen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $307.58.

Check Out Our Latest Analysis on Veeva Systems

Veeva Systems Trading Down 3.0%

Shares of NYSE:VEEV opened at $283.96 on Friday. The stock has a market cap of $46.54 billion, a PE ratio of 58.31, a price-to-earnings-growth ratio of 2.26 and a beta of 0.98. The stock's fifty day simple moving average is $283.44 and its two-hundred day simple moving average is $266.73. Veeva Systems Inc. has a 1-year low of $201.54 and a 1-year high of $310.50.

Veeva Systems (NYSE:VEEV - Get Free Report) last posted its earnings results on Wednesday, August 27th. The technology company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.90 by ($0.64). The firm had revenue of $789.08 million during the quarter, compared to the consensus estimate of $768.49 million. Veeva Systems had a return on equity of 13.72% and a net margin of 27.29%.The business's revenue was up 16.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.62 EPS. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. On average, sell-side analysts forecast that Veeva Systems Inc. will post 4.35 earnings per share for the current fiscal year.

About Veeva Systems

(Free Report)

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.

Further Reading

Institutional Ownership by Quarter for Veeva Systems (NYSE:VEEV)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Veeva Systems Right Now?

Before you consider Veeva Systems, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veeva Systems wasn't on the list.

While Veeva Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.